Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 1175

BRIEF by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc. Defendants' Motion in Limine to preclude Plaintiaff Amgen Inc. From Offering Testimony Concerning Epogen From Fact Witness Dr. Lin Who Lacks Personal Knowledge. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Exhibit D# 5 Exhibit E)(Fleming, Thomas)

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Doc. 1175 Att. 4 Case 1:05-cv-12237-WGY Document 1175-5 Filed 09/27/2007 Page 1 of 4 EXHIBIT D Dockets.Justia.com Case 1:05-cv-12237-WGY Document 1175-5 Filed 09/27/2007 Page 2 of 4 30(b)(6) Deposition of Fu-Kuen Lin, Ph.D. -Volume I 3/28/2007 CONFIDENTIAL Page 1 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS AMGEN, INC., Plaintiff, v. F. HOFFMANN-LA ROCHE, LTD., a Swiss Company, ROCHE DIAGNOSTICS GmbH, a German Company, and HOFFMANN-LA ROCHE, INC., a New Jersey Corporation, Defendants. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Civil Action No. 05-CV-12237-WGY VIDEOTAPED DEPOSITION OF FU-KUEN LIN, PH.D. VOLUME I WESTLAKE VILLAGE, CALIFORNIA MARCH 28, 2007 (This transcript contains testimony designated confidential as per Section 5(c) of the Amended Protective Order. Please treat the entire transcript in accordance with the protective order.) Reported by: Harry Alan Palter, C.S.R. NO. 7708 LiveNote World Service 800.548.3668 Ext. 1 Case 1:05-cv-12237-WGY Document 1175-5 Filed 09/27/2007 Page 3 of 4 30(b)(6) Deposition of Fu-Kuen Lin, Ph.D. -Volume I 3/28/2007 CONFIDENTIAL Page 260 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Q THE WITNESS: BY MS. BEN-AMI: Q group? MR. MADRID: BY MS. BEN-AMI: Q A Q Right? Hmm-hmm -- yes. Okay. So I don't know that we need to go through this word by word, and go through paragraph by paragraph. So who did the purification work? MR. MADRID: Vague. THE WITNESS: In terms of Objection. Same objection. Radioimmunoassays were Dr. Egrie's Yes. That's correct. purification of erythropoietin? BY MS. BEN-AMI: Q A Yes. Okay. Was done by Tom Strickland's group. Who did the purification work to enable the human EPO to be pure enough to be used as a therapeutic drug? MR. MADRID: Objection. LiveNote World Service 800.548.3668 Ext. 1 Case 1:05-cv-12237-WGY Document 1175-5 Filed 09/27/2007 Page 4 of 4

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?